Immunic, Inc. (NASDAQ:IMUX) Receives $49.25 Average Target Price from Brokerages
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.